Arcoma AB (OSTO:ARCOMA) Total Liabilities: kr26.3 Mil (As of Mar. 2026)


OSTO:ARCOMA Arcoma AB OSTO:ARCOMA
75 GF Score
Price kr8.50
GF Value kr7.86
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Arcoma AB Total Liabilities?

Arcoma AB OSTO:ARCOMA -0.93% 75 Total Liabilities is kr26.3 Mil as of Mar. 2026. GuruFocus rates OSTO:ARCOMA with a GF Score™ of 75/100 and a GF Value™ of kr7.86 (Fairly Valued). The stock has 2 warning signs investors should review.

Arcoma AB's Total Liabilities for the quarter that ended in Mar. 2026 was kr26.3 Mil.

Arcoma AB's quarterly Total Liabilities declined from Sep. 2025 (kr24.58 Mil) to Dec. 2025 (kr21.92 Mil) but then increased from Dec. 2025 (kr21.92 Mil) to Mar. 2026 (kr26.30 Mil).

Arcoma AB's annual Total Liabilities declined from Dec. 2023 (kr33.31 Mil) to Dec. 2024 (kr21.13 Mil) but then increased from Dec. 2024 (kr21.13 Mil) to Dec. 2025 (kr21.92 Mil).

Arcoma AB Total Liabilities Historical Data

* Premium members only.

The historical data trend for Arcoma AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arcoma AB Total Liabilities Chart

Arcoma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.23 54.46 33.31 21.13 21.92

Arcoma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.87 19.58 24.58 21.92 26.30
OSTO:ARCOMA
75GF Score
Arcoma AB OSTO:ARCOMA
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arcoma AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Arcoma AB's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=21.924+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=21.9

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=96.651-74.727
=21.9

Arcoma AB's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=26.304+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=26.3

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=101.842-75.538
=26.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of kr26.3 Mil mean?
Arcoma AB (OSTO:ARCOMA) has a Total Liabilities of kr26.3 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Arcoma AB and its competitors.
Is Arcoma AB's Total Liabilities too high?
Arcoma AB's current Total Liabilities is kr26.3 Mil. Overall, Arcoma AB has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Arcoma AB's Total Liabilities compare to ABT and SYK?
Arcoma AB's Total Liabilities of kr26.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Arcoma AB and its competitors. Arcoma AB's current Total Liabilities is kr26.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcoma AB stock overvalued right now?
Based on GuruFocus' analysis, Arcoma AB (OSTO:ARCOMA) is currently considered Fairly Valued. The stock's GF Value™ is kr7.86, compared to a current price of kr8.50 — trading 8.1% above its estimated fair value. The current Total Liabilities is kr26.3 Mil. Arcoma AB's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Arcoma AB (OSTO:ARCOMA), the current Total Liabilities is kr26.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arcoma AB (OSTO:ARCOMA) Overvalued in 2026?

Based on GuruFocus' analysis, Arcoma AB stock appears to be overvalued. The current stock price of kr8.50 is trading 8.1% above its estimated GF Value™ of kr7.86. GuruFocus considers Arcoma AB to be Fairly Valued.

Key valuation signals for OSTO:ARCOMA:

  • Total Liabilities: kr26.3 Mil
  • GF Value™: kr7.86 vs. price of kr8.50 (8.1% above fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the OSTO:ARCOMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arcoma AB Business Description

Address Annavagen 1, Vaxjo, SWE, SE-352 46
Arcoma AB provides digital radiography systems in Sweden. It offers products including wireless flat panel detectors, positioning devices, and precision dr systems.
75GF Score

Get the complete analysis for OSTO:ARCOMA

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.50
Price
kr7.86
GF Value